Search Results 401-410 of 10104 for SC

  1. Publications - Thomas G. Osborn, M.D. - Mayo Clinic

    Lung ultrasound surface wave elastography IEEE International Ultrasonics Symposium, IUS. 2016; 2016-November:7728512. Abdellatief A, Balasubramaniam SC, Grube ...

  2. Stroke Core Measure - Mayo Clinic

    SC: Mayo Clinic Breadcrumb. About Mayo Clinic · Quality & Mayo Clinic · Quality measures. Sections Quality measures. Arizona · Florida · Minnesota · Event ...

  3. Judy C. Boughey, M.D. - Doctors and Medical Staff - Mayo Clinic

    She completed her residency at the University of South Carolina and her breast surgery fellowship at the University of Texas, M.D. Anderson Cancer Center. In ...

  4. Cancer Treatment Clinical Trials - Mayo Clinic Research

    This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...

  5. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

    The purpose of this randomized, double-blind study is to investigate the efficacy and safety of mepolizumab (300 milligram [mg] administered subcutaneously [SC] ...

  6. A Phase 3 Study to Examine the Effectiveness, Safety and Tolerability of APL-130277 for the Acute Treatment of Motor Fluctuation Episodes in Patients with Parkinson's Disease - Mayo Clinic

    continuous s.c. apomorphine infusion; or Duodopa/Duopa. Treatment with any form of s.c. apomorphine within 7 days prior to the initial screening visit (SV1).

  7. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    ... SC dose at Week 0, followed by one 40 mg SC dose at Week 2, in countries where this dosing regimen is approved]);; At least one 4-week induction regimen ...

  8. Publications - Maria Alice V. Willrich, Ph.D. - Mayo Clinic

    ... SC, Sridharan M. Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation. Blood Adv. 2023 Feb ...

  9. Publications - Hatem Amer, M.D. - Mayo Clinic

    ... SC, Kremers WK, Lerman LO. Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors ...

  10. A Study to Examine the Long-Term Safety, Tolerability and Effectiveness of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients with Parkinson's Disease - Mayo Clinic

    Treatment with any form of s.c. apomorphine within 7 days prior to the initial Screening Visit (SV1). Patients that stopped s.c. apomorphine for any reason ...